FDA Seizes Cosmetic Eye Product Over Eye Injury Concerns
At the request of the U.S. Food and Drug Administration (FDA), U.S. Marshals recently seized more than 12,000 tubes of cosmetic eyelash product worth approximately $2 million, because the product contained undeclared bimatoprost -- a prescription drug ingredient used in the treatment of increased eye pressure.
The product, Age Intervention Eyelash dispensed in applicator tubes, put consumers at risk of optic nerve damage, swelling of the retina and eye inflammation, conditions which can cause decreased vision.
The FDA recommends that consumers, dermatologists, and estheticians who still have remaining supplies of Age Intervention Eyelash discontinue using it and discard the product. The agency also recommends that consumers consult their health care provider if they have experienced any adverse events that they suspect are related to the use of the eyelash product.
Previously on the DC Metro Area Medical Malpractice Law Blog, we have posted articles related to:
- The danger of beta-blocker eye drops
- A study linking poor eye health to early death
- A recall of contact lens solution over parasitic infection
For information about your legal rights, please click here or call the law firm of Regan Zambri & Long, PLLC at 202-463-3030.